Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori

Journal of Gastroenterology

Volumn 32, Issue 1, 1997, Pages 24-27

  Moayyedi, P ^a   Chalmers, D M ^a   Axon, A T R ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Eradication; Gender; H2 receptor antagonist; Helicobacter pylori; Smoking

Indexed keywords

CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; MACROLIDE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR; TINIDAZOLE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBACTERIAL ACTIVITY; ARTICLE; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; TREATMENT FAILURE;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; REGRESSION ANALYSIS; SEX FACTORS; SMOKING; TINIDAZOLE; TREATMENT FAILURE;

EID: 0031045830     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01213292     Document Type: Article

References (23)

1. Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol 1994;6:773-777.
2. Goddard A, Logan R. One-week low-dose triple therapy: New standards for Helicobacter pylori treatment. Eur J Gastroenterol 1995;7:1-3.
3. Logan RPH, Gummett PA, Misiewicz JJ, et al. One-week eradication regimen for Helicobacter pylori. Lancet 1991;338:1249-1252.
4. Bell GD, Powell K, Burridge SM, et al. Experience with "triple" anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992;6:427-435.
5. Moayyedi P, Sahay P, Tompkins DS. Efficacy and optimum dose of omeprazole in new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-840.
6. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-496.
7. Labenz J, Stolte M, Ruhl GH, Becker T, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9-11.
8. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxycillin for the cure of Helicobacter pylori infection - factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-1075.
9. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3:915-921.
10. Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325-331.
11. Witteman EM, Hopman WPM, Becx MCJM, et al. Short report: Smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis. Aliment Pharmacol Ther 1993;7:683-687.
12. Blair AJ, Feldman M, Barnett C, et al. Detailed comparison of basal and food-stimulated gastric acid secretion in normal subjects and patients with duodenal ulcer. J Clin Inv 1987;79:582-587.
13. Labenz J, Stolte M, Blum AL, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: A study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995;37:39-43.
14. Holm L, Perry MA. Role of blood flow in gastric acid secretion. Am J Physiol 1988;G281-G293.
15. Adamek RJ, Wegener M, Labenz J, et al. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994;89:39-42.
16. Pullar T, Kumar S, Tindall H. Time to stop counting tablets? Clin Pharmacol Ther 1989;46:163-168.
17. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29(Suppl 201):16-23.
18. 2-receptor blockade in cats. Scand J Gastroenterol 1983;18:977-986.
19. Holm-Rutili L. Effects of omeprazole on gastric micro-circulation in the rat. Gastroenterology 1987;92:716-723.
20. Polansky DB, Shirazi SS, Coon D. Lack of correlation of gastric acid secretion and blood flow. J Surg Res 1979;26:320-325.
21. Kauffman GL, Aures D, Grossman MI. Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow. Am J Physiol 1980;238:G131-G138.
22. Prewett EJ, Smith JTL, Nwokolo CU, et al. Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci 1991;80:619-624.
23. Bode G, Mauch F, Malfertheiner P. The coccoid forms of Helicobacter pylori. Criteria for their viability. Epidemiol Infect 1993;111:483-490.